Skip to content
Virax Biolabs

Innovating Immune Resistance Testing

  • ViraxImmune™
  • Media
  • Leadership
  • Contact
  • Investor Relations
  • ViraxImmune™
  • Media
  • Leadership
  • Contact
  • Investor Relations

James Foster CEO & Nigel McCracken COO – Virax Biolabs (with Don Davis PhD)

Virax Biolabs Partners With University of Manchester, Northern Care Alliance on Long COVID Study

Identifying Post-Viral Syndromes Such as Long COVID

by John Parkinson

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Virax Biolabs’ CEO James Foster Issues Letter to Shareholders

Dr. Nigel McCracken, Ph.D. – Chief Operating Officer, Virax Biolabs

16 Clinical Laboratory Predictions for 2024 (featuring James Foster)

“Regulatory reforms and incentives implemented by Middle Eastern countries have simplified market entry for life sciences companies” (featuring James Foster)

By Ayesha Siddiqui

Could a Predictive Test Fuel a Diagnostic Revolution? (featuring James Foster)

T Cell Secrets by James Foster

← Previous
Next →

BioCity Glasgow
Bo’Ness Road, Newhouse
Lanarkshire
ML1 5UH
United Kingdom

Quick links

  • Discover ViraxImmune™ Novel PAIS Diagnostic Development
  • Custom Immunology Services By Virax Biolabs
  • Terms and Conditions
  • News And Media Updates From Virax Biolabs
  • Meet Virax Biolabs’ Leadership Team and Advisory Board
  • Contact
  • Investor Relations
  • Discover ViraxImmune™ Novel PAIS Diagnostic Development
  • Custom Immunology Services By Virax Biolabs
  • Terms and Conditions
  • News And Media Updates From Virax Biolabs
  • Meet Virax Biolabs’ Leadership Team and Advisory Board
  • Contact
  • Investor Relations

Subscribe to Our Newsletter

You can cancel subscription any time

Follow us

Facebook Twitter Linkedin Instagram
© All Rights Reserved, Virax Biolabs 2026 | Privacy Policy | Terms of Service